Three-Year Follow-Up Of Neoadjuvant Chemotherapy With Or Without Anthracyclines In The Presence Of Dual Her2-Blockade For Her2-Positive Breast Cancer (Train-2): A Randomized Phase Iii Trial.
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
501Background: The multicenter phase III TRAIN-2 study showed high pathological complete response (pCR) rates after neoadjuvant chemotherapy with and without anthracylines plus dual HER2-blockade i...
更多查看译文
关键词
neoadjuvant chemotherapy,breast cancer,three-year
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要